• CLOSE

Coronavirus Panel

COVID 19 LP Panel

About Us

In Vitro Technologies’ Diagnostics Division represents leading global companies in both Clinical and Veterinary Pathology, to deliver customised solutions for all areas of pathology.

Each Diagnostics team member have extensive laboratory and commercial experience and, along with technical support and customer care professionals, are committed to providing quality and responsive after-sales service and support.

Learn more about our customised solutions

 

All news

Latest News & Events

Apr 26, 2017

Break the chain of Infection!

Distributed to the Medical/Healthcare sector by In Vitro Technologies.

Dec 3, 2016

Serum free immunoglobulin light chain fingerprint identifies a subset of newly diagnosed multiple myeloma patients with worse outcome.

Avivi I, Cohen YC, Joffe E, Benyamini N, Held-Kuznetsov V, Trestman S, et al. Serum free immunoglobulin light chain fingerprint identifies a subset of newly diagnosed multiple myeloma patients with worse outcome. Hematol Oncol 2016.

Dec 3, 2016

Evaluation of the Impact of Renal Failure on Correlation and Concordance between 2 Free Light Chain Assays

Moreau C, Autier B, Cavey T, Rouger E, Norwood J, Bendavid C, et al. Evaluation of the Impact of Renal Failure on Correlation and Concordance between 2 Free Light Chain Assays. Clin Lymphoma Myeloma Leuk 2016.

Nov 16, 2016

AIMS & AACB Christmas Quiz

All we want for Christmas is for you to join us for Trivia! The Queensland Branch of AIMS and AACB would like to invite you to this year’s joint Christmas Quiz and Function.